aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company (“aVenture”) is an independent research platform providing information and analysis about startups.
Certain metrics provided by aVenture may seek to assess the risks and opportunities associated with a company, fund, or its representatives (collectively “research”). aVenture seeks to provide this information with objectivity and fairness, and with diligence about its accuracy. Nonetheless, aVenture cannot provide assurance as to the accuracy of the information provided by our research. We strongly advise those using the research platform to seek multiple, independent sources for your research when making financial decisions.
Any links provided to other websites are offered as a matter of convenience and are not intended to imply that aVenture or its authors endorse, sponsor, promote, and/or are affiliated with the owners of or participants in those sites.
The aVenture platform also provides investment listings offered by independent investment advisers in the United States. aVenture is neither a registered investment adviser nor an exempt reporting adviser under the Investment Advisers Act of 1940, and no statements made by aVenture are intended to imply any financial instruments are under the counsel or advice of aVenture or its representatives.
Funds offered on the platform are generally managed by a private investment adviser that, unless stated otherwise, claims exemption from SEC or state registration. Investment funds presented on the platform are only available to investors who meet the requirements of the offering, and solicitations are not made outside those listed jurisdictions.
Additionally, each investment offered on the platform has qualifications for eligibility, including some offered only to Qualified Clients and/or Accredited Investors. Certain funds may be available to non-Qualified or Accredited investors, but only those who become personally known and identifiable to aVenture Investment Company staff, who have had an opportunity to assess the financial capacity and suitability for such an investment, and discuss its risks. Funds, when offered, are only offered following a review of a Private Placement Memorandum (PPM), subscription agreement, and other disclosures.
Investments in startups, venture capital, angel investments, private equity, real estate, stocks, and similar asset classes all involve risks, including: the risk of a decline in the value of your investments, including potentially large declines (suddenly and/or for long periods of time), the potential for illiquidity where part or all of a withdrawal request may not be honored on the date requested (even when a feature of the fund). These risks are heightened during periods of market duress.
Diversification has the possibility of reducing the magnitude of declines (either caused by market/economic factors, or by factors related to the individual company), but does not guarantee these risks have been fully or partially alleviated. Most importantly, past results are not an assurance of future outcomes. While most of these risks are shared and similarly held by other investment asset classes, we recommend investors only consider venture capital investments as part of a broader, diversified portfolio of stocks, bonds, and immediately accessible cash reserves.
From Startups | TechCrunch
By Tim De Chant
April 12, 2024
For decades, building material companies have shredded old newspapers to create cellulose insulation. But as newspapers have declined, the cellulose insulation industry has found itself in a bind, chasing after dwindling supplies of raw material.
As old newsprint has become harder to find, there’s been another paper-based product on the rise: corrugated cardboard. People have increasingly turned to e-commerce, and the amount of cardboard boxes has crept steadily upward. Every year, as much as 50 million tons of the material land in waste and recycling bins.
Cardboard would seem like a perfect, paper-based solution to the insulation industry’s short supply, except there’s one problem: Corrugated boxes are riddled with contaminants like plastic tape, shipping labels and even metal staples. Transforming it into insulation is far more challenging than newsprint ever was. Yet one startup, CleanFiber, anticipated the shift and has been working on the problem for years.
To date, CleanFiber has been able to produce enough insulation for about 20,000 single-family homes. But CEO Jonathan Strimling knew that the company would have to stretch beyond its initial factory in Buffalo, New York, if it were to become more than an afterthought. The insulation market in the U.S. is dominated by a handful of large players and is worth $12.5 billion, according to Grand View Research.
Strimling also knew that he and his team would need more capital to expand. They last raised a $10 million Series A in 2022 using a creative mix of equity and debt to get the Buffalo plant running at full steam. But a nationwide expansion would require a much larger war chest.
Fortunately, the company had been courting Spring Lane Capital, a sustainability-focused private equity firm, for over a decade. The firm had been watching CleanFiber’s progress and, happy with the numbers the startup was posting, decided to lead a $28 million Series B that also included a $31.5 million project financing facility, TechCrunch has exclusively learned. Spring Lane was joined by Ahlström Invest, AXA Investment Managers, Climate Innovation Capital and Tokyu Construction/Global Brain.
“It puts us in a very, very strong position to roll out nationally,” Strimling told TechCrunch.
Using an entirely new process to transform a different feedstock into a drop-in replacement for existing cellulose insulation was one challenge the company faced when developing its product. It couldn’t cost any more, and it had to perform as well or better for the installers who deal with it on a daily basis.
CleanFiber has been selling its bales at market prices while refining its production process. Strimling didn’t disclose whether the company is making the product profitably yet, but he did say that CleanFiber has been able to “bring the marginal cost of production down a very, very significant curve.”
With a first-of-its-kind plant built and operational, CleanFiber has been able to traverse one of the most treacherous parts of the valley of death that often claims startups trying to commercialize a new technology. Building new additional factories won’t be a walk in the park, but it should get easier with each subsequent one. Plus, Strimling points out that more stringent building codes mean that new homes require more insulation than ever before. In other words, CleanFiber doesn’t need established players to lose for it to win.
View original article on techcrunch.com
Share:
Xaira, an AI drug discovery startup, launches with a massive $1B, says it’s ‘ready’ to start developing drugs
Advances in generative AI have taken the tech world by storm. Biotech investors are making a big bet that similar computational methods could revolutionize drug discovery. On Tuesday, ARCH Venture Partners and Foresite Labs, an affiliate of Foresite Capital, announced that they incubated Xaira Therapeutics and funded the AI biotech with $1 billion. Other investors […] © 2024 TechCrunch. All rights reserved. For personal use only.
Apr 25, 2024
Eric Schmidt-backed Augment, a GitHub Copilot rival, launches out of stealth with $252M
AI is supercharging coding — and developers are embracing it. In a recent StackOverflow poll, 44% of software engineers said that they use AI tools as part of their development processes now and 26% plan to soon. Gartner estimates that over half of organizations are currently piloting or have already deployed AI-driven coding assistants, and […] © 2024 TechCrunch. All rights reserved. For personal use only.
Apr 24, 2024
Radical thinks the time has come for solar-powered, high-altitude autonomous aircraft
Though many eyes are on space as orbit develops into a thriving business ecosystem, Radical is keeping things a little closer to the ground — but not too close. Its high-altitude, solar-powered aircraft aim to succeed where Facebook’s infamous Aquila failed by refining the tech and embracing more markets. It’s hard to believe that Facebook’s […] © 2024 TechCrunch. All rights reserved. For personal use only.
Apr 24, 2024
Don't miss our latest news and updates. Subscribe to the newsletter
More from Tech Crunch: